Stimulation of angiotensin type 1A receptors on catecholaminergic cells contributes to angiotensin-dependent hypertension

Hypertension

Volumn 62, Issue 5, 2013, Pages 866-871

  Jancovski, Nikola ^a   Bassi, Jaspreet K ^a   Carter, David A ^a   Choong, Yan Ting ^a   Connelly, Angela ^a   Nguyen, Thu Phuc ^b   Chen, Daian ^a,d   Lukoshkova, Elena V ^c   Menuet, Clement ^a   Head, Geoffrey A ^b   Allen, Andrew M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b BAKER IDI HEART AND DIABETES INSTITUTE   (Australia)

^c INSTITUTE OF EXPERIMENTAL CARDIOLOGY   (Russian Federation)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

blood pressure; brain; receptor, angiotensin, type 1; tyrosine 3 monooxygenase

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1A RECEPTOR; ANGIOTENSIN II; CRE RECOMBINASE; REACTIVE OXYGEN METABOLITE; ANGIOTENSIN 1 RECEPTOR; CATECHOLAMINE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ATTENUATION; BASAL METABOLIC RATE; BLOOD PRESSURE; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; DRUG INFUSION; FEMALE; FOREBRAIN; HEART VENTRICLE HYPERTROPHY; HYPERTENSION; LOXP SITE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ROSTRAL VENTROLATERAL MEDULLA; SPECTRAL SENSITIVITY; SUBFORNICAL ORGAN; THALAMUS VENTRAL NUCLEUS; ANIMAL; CARDIOMEGALY; CHEMICALLY INDUCED; DRUG EFFECTS; GENETICS; KNOCKOUT MOUSE; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CARDIOMEGALY; CATECHOLAMINES; HYPERTENSION; MICE; MICE, KNOCKOUT; REACTIVE OXYGEN SPECIES; RECEPTOR, ANGIOTENSIN, TYPE 1; SUBFORNICAL ORGAN; SYMPATHETIC NERVOUS SYSTEM;

EID: 84886438550     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.113.01474     Document Type: Article

References (42)

1. Roger VL, Go AS, Lloyd-Jones DM, et al. Executive summary: heart disease and stroke statistics-2012 update: a report from the American Heart Association. Circulation. 2012;125:188-197.
2. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev. 2006;86:747-803.
3. Guyton AC, Cowley AW Jr, Young DB, Coleman TG, Hall JE, DeClue JW. Integration and control of circulatory function. Int Rev Physiol. 1976;9:341-385.
4. Guyton AC. Blood pressure control-special role of the kidneys and body fluids. Science. 1991;252:1813-1816.
5. Gurley SB, Riquier-Brison AD, Schnermann J, Sparks MA, Allen AM, Haase VH, Snouwaert JN, Le TH, McDonough AA, Koller BH, Coffman TM. AT1A angiotensin receptors in the renal proximal tubule regulate blood pressure. Cell Metab. 2011;13:469-475.
6. Li H, Weatherford ET, Davis DR, Keen HL, Grobe JL, Daugherty A, Cassis LA, Allen AM, Sigmund CD. Renal proximal tubule angiotensin AT1A receptors regulate blood pressure. Am J Physiol Regul Integr Comp Physiol. 2011;301:R1067-R1077.
7. Crowley SD, Gurley SB, Herrera MJ, Ruiz P, Griffiths R, Kumar AP, Kim HS, Smithies O, Le TH, Coffman TM. Angiotensin II causes hypertension and cardiac hypertrophy through its receptors in the kidney. Proc Natl Acad Sci U S A. 2006;103:17985-17990.
8. Judy WV, Farrell SK. Arterial baroreceptor reflex control of sympathetic nerve activity in the spontaneously hypertensive rat. Hypertension. 1979;1:605-614.
9. Moretti JL, Burke SL, Davern PJ, Evans RG, Lambert GW, Head GA. Renal sympathetic activation from long-term low-dose angiotensin II infusion in rabbits. J Hypertens. 2012;30:551-560.
10. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic- nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-934.
11. Simms AE, Paton JF, Pickering AE, Allen AM. Amplified respiratorysympathetic coupling in the spontaneously hypertensive rat: does it contribute to hypertension? J Physiol. 2009;587(Pt 3):597-610.
12. Allen AM, Moeller I, Jenkins TA, Zhuo J, Aldred GP, Chai SY, Mendelsohn FA. Angiotensin receptors in the nervous system. Brain Res Bull. 1998;47:17-28.
13. Story DF, Ziogas J. Interaction of angiotensin with noradrenergic neuroeffector transmission. Trends Pharmacol Sci. 1987;8:269-271.
14. Allen AM, Chai SY, Clevers J, McKinley MJ, Paxinos G, Mendelsohn FA. Localization and characterization of angiotensin II receptor binding and angiotensin converting enzyme in the human medulla oblongata. J Comp Neurol. 1988;269:249-264.
15. Chen D, Jancovski N, Bassi JK, Nguyen-Huu TP, Choong YT, Palma- Rigo K, Davern PJ, Gurley SB, Thomas WG, Head GA, Allen AM. Angiotensin type 1A receptors in C1 neurons of the rostral ventrolateral medulla modulate the pressor response to aversive stress. J Neurosci. 2012;32:2051-2061.
16. Jenkins TA, Allen AM, Chai SY, Mendelsohn FA. Interactions of angiotensin II with central catecholamines. Clin Exp Hypertens. 1995;17:267-280.
17. Lindeberg J, Usoskin D, Bengtsson H, Gustafsson A, Kylberg A, Söderström S, Ebendal T. Transgenic expression of Cre recombinase from the tyrosine hydroxylase locus. Genesis. 2004;40:67-73.
18. Marvar PJ, Thabet SR, Guzik TJ, Lob HE, McCann LA, Weyand C, Gordon FJ, Harrison DG. Central and peripheral mechanisms of T-lymphocyte activation and vascular inflammation produced by angiotensin II-induced hypertension. Circ Res. 2010;107:263-270.
19. Young CN, Cao X, Guruju MR, Pierce JP, Morgan DA, Wang G, Iadecola C, Mark AL, Davisson RL. ER stress in the brain subfornical organ mediates angiotensin-dependent hypertension. J Clin Invest. 2012;122:3960-3964.
20. Braga VA, Medeiros IA, Ribeiro TP, França-Silva MS, Botelho-Ono MS, Guimarães DD. Angiotensin-II-induced reactive oxygen species along the SFO-PVN-RVLM pathway: implications in neurogenic hypertension. Braz J Med Biol Res. 2011;44:871-876.
21. Zimmerman MC, Lazartigues E, Sharma RV, Davisson RL. Hypertension caused by angiotensin II infusion involves increased superoxide production in the central nervous system. Circ Res. 2004;95:210-216.
22. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci. 2006;7:335-346.
23. Lewis GP, Reit E. The action of angiotensin and bradykinin on the superior cervical ganglion of the cat. J Physiol. 1965;179:538-553.
24. Ma X, Sigmund CD, Hingtgen SD, Tian X, Davisson RL, Abboud FM, Chapleau MW. Ganglionic action of angiotensin contributes to sympathetic activity in renin-angiotensinogen transgenic mice. Hypertension. 2004;43:312-316.
25. Osborn JW, Fink GD. Region-specific changes in sympathetic nerve activity in angiotensin II-salt hypertension in the rat. Exp Physiol. 2010;95:61-68.
26. Buggy J, Fink GD, Johnson AK, Brody MJ. Prevention of the development of renal hypertension by anteroventral third ventricular tissue lesions. Circ Res. 1977;40(5 Suppl 1):I110-I117.
27. Haywood JR, Fink GD, Buggy J, Boutelle S, Johnson AK, Brody MJ. Prevention of two-kidney, one-clip renal hypertension in rat by ablation of AV3V tissue. Am J Physiol. 1983;245:H683-H689.
28. Ebert SN, Thompson RP. Embryonic epinephrine synthesis in the rat heart before innervation: association with pacemaking and conduction tissue development. Circ Res. 2001;88:117-124.
29. Mezey E, Eisenhofer G, Harta G, Hansson S, Gould L, Hunyady B, Hoffman BJ. A novel nonneuronal catecholaminergic system: exocrine pancreas synthesizes and releases dopamine. Proc Natl Acad Sci U S A. 1996;93:10377-10382.
30. Eisenhofer G, Aneman A, Friberg P, Hooper D, Fandriks L, Lonroth H, Hunyady B, Mezey E. Substantial production of dopamine in the human gastrointestinal tract. J Clin Endocrinol Metab. 1997;82:3864-3871.
31. Musso NR, Brenci S, Setti M, Indiveri F, Lotti G. Catecholamine content and in vitro catecholamine synthesis in peripheral human lymphocytes. J Clin Endocrinol Metab. 1996;81:3553-3557.
32. Qiu YH, Peng YP, Jiang JM, Wang JJ. Expression of tyrosine hydroxylase in lymphocytes and effect of endogenous catecholamines on lymphocyte function. Neuroimmunomodulation. 2004;11:75-83.
33. Vargovic P, Ukropec J, Laukova M, Cleary S, Manz B, Pacak K, Kvetnansky R. Adipocytes as a new source of catecholamine production. FEBS Lett. 2011;585:2279-2284.
34. Pullar CE, Rizzo A, Isseroff RR. beta-Adrenergic receptor antagonists accelerate skin wound healing: evidence for a catecholamine synthesis network in the epidermis. J Biol Chem. 2006;281:21225-21235.
35. Zhang JD, Patel MB, Song YS, Griffiths R, Burchette J, Ruiz P, Sparks MA, Yan M, Howell DN, Gomez JA, Spurney RF, Coffman TM, Crowley SD. A novel role for type 1 angiotensin receptors on T lymphocytes to limit target organ damage in hypertension. Circ Res. 2012;110:1604-1617.
36. Sparks MA, Parsons KK, Stegbauer J, Gurley SB, Vivekanandan-Giri A, Fortner CN, Snouwaert J, Raasch EW, Griffiths RC, Haystead TA, Le TH, Pennathur S, Koller B, Coffman TM. Angiotensin II type 1A receptors in vascular smooth muscle cells do not influence aortic remodeling in hypertension. Hypertension. 2011;57:577-585.
37. Crowley SD, Zhang J, Herrera M, Griffiths R, Ruiz P, Coffman TM. Role of AT1 receptor-mediated salt retention in angiotensin II-dependent hypertension. Am J Physiol Renal Physiol. 2011;301: F1124-F1130.
38. Ando K, Fujita T. Pathophysiology of salt sensitivity hypertension. Ann Med. 2012;44(Suppl 1):S119-S126.
39. McDonough AA. Mechanisms of proximal tubule sodium transport regulation that link extracellular fluid volume and blood pressure. Am J Physiol Regul Integr Comp Physiol. 2010;298:R851-R861.
40. Mu S, Shimosawa T, Ogura S, Wang H, Uetake Y, Kawakami-Mori F, Marumo T, Yatomi Y, Geller DS, Tanaka H, Fujita T. Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med. 2011;17:573-580.
41. Heusser K, Tank J, Engeli S, Diedrich A, Menne J, Eckert S, Peters T, Sweep FC, Haller H, Pichlmaier AM, Luft FC, Jordan J. Carotid baroreceptor stimulation, sympathetic activity, baroreflex function, and blood pressure in hypertensive patients. Hypertension. 2010;55:619-626.
42. Bisognano JD, Bakris G, Nadim MK, Sanchez L, Kroon AA, Schafer J, de Leeuw PW, Sica DA. Baroreflex activation therapy lowers blood pressure in patients with resistant hypertension: results from the double-blind, randomized, placebo-controlled rheos pivotal trial. J Am Coll Cardiol. 2011;58:765-773.